SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Jan-14 4:30 PM View: | Echo Therapeutics, Inc. (ECTE) | 18-Dec-13 | Grant | 14,500 | -- | -- | 173% 8.4K to 22.9K | |
02-Oct-13 2:00 PM View: | Echo Therapeutics, Inc. (ECTE) | 01-Oct-13 | Grant | 400 | -- | -- | 5% 8.0K to 8.4K | |
02-Jul-13 4:30 PM View: | Echo Therapeutics, Inc. (ECTE) | 01-Jul-13 | Grant | 400 | -- | -- | < 1% 76.0K to 76.4K | |
10-Apr-13 4:50 PM View: | Echo Therapeutics, Inc. (ECTE) | 09-Apr-13 | Grant | 4,000 | -- | -- | 6% 72.0K to 76.0K | |
11-Jan-13 9:50 AM View: | Echo Therapeutics, Inc. (ECTE) | 10-Jan-13 | Grant | 6,250 | -- | -- | 10% 65.75K to 72.0K | |
02-Oct-12 4:15 PM View: | Echo Therapeutics, Inc. (ECTE) | 30-Sep-12 | Grant | 6,250 | -- | -- | 11% 59.5K to 65.75K | |
23-Aug-12 1:42 PM View: | Echo Therapeutics, Inc. (ECTE) | 23-Aug-12 | Market Purchase | 6,400 | $1.47 | $9,408.00 | 12% 53.1K to 59.5K | (98%) |
23-Aug-12 1:42 PM View: | Echo Therapeutics, Inc. (ECTE) | 22-Aug-12 | Market Purchase | 13,600 | $1.47 | $19,992.00 | 34% 39.5K to 53.1K | (98%) |
03-Jul-12 4:05 PM View: | Echo Therapeutics, Inc. (ECTE) | 30-Jun-12 | Grant | 6,250 | -- | -- | 19% 33.25K to 39.5K | |
13-Dec-11 4:55 PM View: | Orchid Cellmark Inc. (ORCH) | 09-Dec-11 | Disposition (change in control) | 3,100 | $2.80 | $8,680.00 | (100%) 3.1K to 0 | 1% |
18-Feb-11 5:27 PM View: | Echo Therapeutics, Inc. (ECTE) | 16-Feb-11 | Grant | 20,000 | -- | -- | 286% 7.0K to 27.0K | |
06-Aug-08 1:41 PM View: | Orchid Cellmark Inc. (ORCH) | 05-Aug-08 | Market Purchase | 3,100 | $3.37 | $10,447.00 | 100% 0 to 3.1K | (71%) |
25-Apr-05 7:40 PM View: | Aphton Corp. (APHTQ.PK) | 21-Apr-05 | Grant | 25,000 | -- | -- | 167% 15.0K to 40.0K | |
18-Mar-05 3:54 PM View: | Aphton Corp. (APHTQ.PK) | 17-Mar-05 | Market Purchase | 15,000 | $1.24 | $18,600.00 | 100% 0 to 15.0K |